Xenetic Biosciences (XBIO) Equity Ratio (2023 - 2025)
Xenetic Biosciences (XBIO) has disclosed Equity Ratio for 5 consecutive years, with 0.78 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Equity Ratio fell 10.74% year-over-year to 0.78, compared with a TTM value of 0.78 through Sep 2025, down 10.74%, and an annual FY2024 reading of 0.87, down 5.76% over the prior year.
- Equity Ratio was 0.78 for Q3 2025 at Xenetic Biosciences, down from 0.83 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.94 in Q1 2023 and bottomed at 0.78 in Q3 2025.
- Average Equity Ratio over 3 years is 0.88, with a median of 0.88 recorded in 2025.
- The sharpest move saw Equity Ratio dropped 11.53% in 2024, then grew 0.85% in 2025.
- Year by year, Equity Ratio stood at 0.92 in 2023, then dropped by 5.76% to 0.87 in 2024, then fell by 10.32% to 0.78 in 2025.
- Business Quant data shows Equity Ratio for XBIO at 0.78 in Q3 2025, 0.83 in Q2 2025, and 0.88 in Q1 2025.